![Donato Spota](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Donato Spota served as the Chief Financial Officer at Basilea Pharmaceutica AG from 2013 to 2019.
He then joined Hansa Biopharma AB as the Chief Financial Officer & Senior Vice President in 2019, a position he held until 2024.
Mr. Spota holds an MBA from Hochschule für Wirtschaft & Umwelt Nürtingen-Geislingen.
Anciens postes connus de Donato Spota
| Sociétés | Poste | Fin |
|---|---|---|
| HANSA BIOPHARMA AB | Directeur Financier/CFO | 28/02/2024 |
| BASILEA PHARMACEUTICA AG | Directeur Financier/CFO | 10/04/2019 |
Formation de Donato Spota
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
33
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Basilea Pharmaceutica AG
 Basilea Pharmaceutica AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Hochschule für Wirtschaft & Umwelt Nürtingen-Geislingen
 Hochschule für Wirtschaft & Umwelt Nürtingen-Geislingen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hansa Biopharma AB
 Hansa Biopharma AB Pharmaceuticals: MajorHealth Technology Develops therapies and medicines for the treatment of immunomodulatory | Health Technology |
